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The age-associated reduction in the proliferation of neural stem cells (NSCs) has been
associated with cognitive decline. Numerous factors have been shown to modulate this
process, including dietary components. Frequent consumption of caffeine has been
correlated with an increased risk of cognitive decline, but further evidence of a negative
effect on hippocampal progenitor proliferation is limited to animal models. Here, we
used a human hippocampal progenitor cell line to investigate the effects of caffeine
on hippocampal progenitor integrity and proliferation specifically. The effects of five
caffeine concentrations (0 mM = control, 0.1 mM ∼ 150 mg, 0.25 mM ∼ 400 mg,
0.5 mM ∼ 750 mg, and 1.0 mM ∼ 1500 mg) were measured following acute (1 day) and
repeated (3 days) exposure. Immunocytochemistry was used to quantify hippocampal
progenitor integrity (i.e., SOX2- and Nestin-positive cells), proliferation (i.e., Ki67-positive
cells), cell count (i.e., DAPI-positive cells), and apoptosis (i.e., CC3-positive cells). We
found that progenitor integrity was significantly reduced in supraphysiological caffeine
conditions (i.e., 1.0 mM ∼ 1500 mg), but relative to the lowest caffeine condition (i.e.,
0.1 mM ∼ 150 mg) only. Moreover, repeated exposure to supraphysiological caffeine
concentrations (i.e., 1.0 mM ∼ 1500 mg) was found to affect proliferation, significantly
reducing % Ki67-positive cells relative to control and lower caffeine dose conditions
(i.e., 0.1 mM ∼ 150 mg and 0.25 mM ∼ 400 mg). Caffeine treatment did not influence
apoptosis and there were no significant differences in any measure between lower doses
of caffeine (i.e., 0.1 mM, 0.25 mM, 0.5 mM) – representative of daily human caffeine
intake – and control conditions. Our study demonstrates that dietary components such
as caffeine can influence NSC integrity and proliferation and may be indicative of a
mechanism by which diet affects cognitive outcomes.
Keywords: adult hippocampal neurogenesis, diet, caffeine, hippocampal progenitor integrity, hippocampal
progenitor proliferation
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INTRODUCTION
Adult hippocampal neurogenesis (AHN), the formation of new
neurons from neural progenitor cells, has recently regained
considerable attention, particularly in the human hippocampus
(Kempermann et al., 2018; Lucassen et al., 2020). This highly
vascularized “neurogenic niche” retains developmental signals
and morphogens that influence cell proliferation, differentiation,
and survival throughout life (Spalding et al., 2013; Gonçalves
et al., 2016). The rates at which these processes occur have been
associated with hippocampal-dependent learning and memory
functions (Snyder et al., 2005; Clelland et al., 2009; Sahay
et al., 2011) and this association is particularly interesting
when considering aging and cognitive decline, during which
hippocampal function typically deteriorates (Small et al., 2002).
Moreover, neural progenitor proliferation declines in rodents
as aging progresses (Heine et al., 2004; Rao et al., 2006) and
this has been strongly correlated with impaired performance
in spatial memory and learning tasks (Sahay et al., 2011;
Villeda et al., 2011).
This association with cognitive decline presents AHN as
a unique target for preventative interventions. Accordingly,
rescuing later life neurogenesis has recently gained interest and
a focus has been given to the factors that modulate neurogenesis
(Baptista and Andrade, 2018). While neurogenesis is facilitated
by the neurogenic niche, it is not only central nervous system-
derived signals that influence AHN. Indeed, AHN is also
modulated by both the external environment (Lledo et al., 2006)
and the system milieu (Villeda et al., 2011; Yousef et al., 2019).
For example, stress and sleep deprivation have been shown to
reduce AHN (Gould et al., 1998; Hairston et al., 2005; Lucassen
et al., 2010), while running increases neurogenesis (van Praag
et al., 2005). Moreover, these environmental factors have been
similarly correlated with spatial learning and memory (Nilsson
et al., 1999; Oomen et al., 2010, 2014), highlighting the possibility
of leveraging behavioral interventions to target the neurogenic
process and, consequently, cognitive ability.
Diet is another environmental factor that has been shown
to influence the neurogenic process (Stangl and Thuret, 2009;
Miquel et al., 2018; Abbink et al., 2020). Drosophila research
shows that nutritional factors can influence the exit of neural
hippocampal progenitors from quiescence (Chell and Brand,
2010; Spéder and Brand, 2014), and other nutritional-based
changes to the hippocampal progenitor pool have been likewise
demonstrated across other species (Spéder et al., 2011; Sakayori
et al., 2013; Cavallucci et al., 2016). For instance, in humans, the
nutrient-sensing pathways: the mammalian target of rapamycin
(mTOR), sirtuin, and insulin-like growth factor 1, have all
been associated with hippocampal progenitor maintenance (de
Lucia et al., 2020). However, the influence of nutrition and
meal content on the hippocampal progenitor pool occurs in
a complex manner, with the nature of change dependent
on the food groups consumed. For instance, a high fat diet
has been shown to decrease proliferation in rats (Lindqvist
et al., 2006), while omega-3 fatty acids increase proliferation
in lobsters (Beltz et al., 2007). Interestingly, these changes
to proliferation directionally correspond with their associated
cognitive outcomes, as omega-3 has been shown to improve
cognitive outcomes, while high fat diets impair cognitive
performance (Winocur and Greenwood, 2005; Fotuhi et al., 2009;
Witte et al., 2009; Yam et al., 2019). Thus, the variable nature
of meal content and its influence on proliferation may provide
a flexible and unique mechanism of regulating the neurogenic
process within the human population. However, further defining
the dietary components that affect the neurogenic process and
their direction of influence is crucial before such dietary-based
interventions can be developed.
Caffeine, the most widely consumed psychostimulant in
the world (Ferré, 2016), has been widely implicated as
a cognitive modulator (Rosso et al., 2008; Glade, 2010).
Caffeine consumption has traditionally been argued to produce
health benefits on a neurological basis, including protection
against cognitive decline in women aged over 65 years
(Ritchie et al., 2007; Arab et al., 2011). However, we recently
demonstrated a negative effect of caffeine on cognition,
identifying caffeine as one of 22 metabolites predictive of
cognitive decline in an aging population, over a 13-year
period (Low et al., 2019). Further evidence to support a
negative effect of caffeine comes from animal models that
focus on hippocampal neuronal proliferation. Specifically,
when administered chronically, physiologically relevant doses
of caffeine decreased neuronal precursor proliferation in rats
(Wentz and Magavi, 2009), which was further correlated with
impaired hippocampal-dependent learning and memory (Han
et al., 2007). However, due to in vivo imaging constraints (Ho
et al., 2013), the effect of caffeine on human hippocampal
progenitor proliferation has not yet been explored. With the
mixed clinical evidence on the impact of caffeine on cognitive
decline and its large-scale consumption worldwide, further
investigation is warranted. Determining the effects of caffeine on
proliferation and the neurogenic process overall, and ultimately
cognition, will contribute to our understanding of how diet affects
these phenomena, which could assist in the development of
appropriate interventions.
Therefore, this study investigated the effects of caffeine
on human hippocampal progenitor proliferation, focusing
on hippocampal proliferation, progenitor integrity (i.e.,
maintenance of the stem cell pool and proliferative/differentiative
capacity), and progenitor apoptosis. We used a human
hippocampal progenitor cell line, for the first time, to investigate,
(i) the effects of five caffeine concentrations, and (ii) the effects
of acute and repeated exposure to caffeine – all on hippocampal
progenitor integrity, proliferation and apoptosis.
MATERIALS AND METHODS
Cell Line and Culture Conditions
The human fetal hippocampal multipotent progenitor cell line
HPC0A07/03 (HPC; ReNeuron Ltd., Surrey, United Kingdom)
was used in all experiments as previously described (de Lucia
et al., 2020; Smeeth et al., in press). Cells were acquired from
12-week old female fetal tissue in accordance with United States
and United Kingdom ethical and legal guidelines. and transfected
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with the c-mycERTAM gene construct creating an immortalized
cell line that proliferates in the presence of the synthetic drug 4-
hydroxy-tamoxifen (4-OHT) and spontaneously differentiates in
its absence. For further details see Supplementary Material.
HPCs were cultured in reduced modified medium (RMM),
namely Dulbecco’s Modified Eagle’s Media/F12 (DMEM:F12,
Sigma), supplemented with 0.03% human albumin solution
(Zenalb), 100 µg/mL human apo-transferrin, 16.2 µg/mL
human putrescine diHCl, 5 µg/mL human recombinant insulin,
60 ng/mL progesterone, 2 mM L-glutamine and 40 ng/mL
sodium selenite. For proliferation, the medium also included
10 ng/mL human basic fibroblast growth factor (bFGF),
20 ng/mL human epidermal growth factor (EGF) and 100 nM
4-OHT. Cells were grown on tissue culture flasks (Nunclon,
Denmark), incubated at 37◦C, 5% CO2 and saturated humidity,
and were routinely passaged at 80% confluency before being
plated for experiments.
Proliferation Assay
The HPC proliferation assay was carried out as previously
described (de Lucia et al., 2020; Smeeth et al., in press). Briefly,
HPCs were seeded into two 96-well plates (Nunclon, Denmark)
per experiment: one plate for acute (one-time) caffeine treatment,
the other for repeated caffeine treatment. Plates were seeded at a
density of 1.2 × 104, at P21 in caffeine-free proliferation media,
with three technical replicates and three biological replicates.
All cells, excluding the control conditions, received caffeine
treatment 24 h after seeding. Cells undergoing acute treatment
were left undisturbed for 48 h, while cells undergoing repeated
exposure received another caffeine treatment 24 h after the
initial treatment. Control conditions were incubated in caffeine-
free proliferation media in all instances. Seventy-two hours
after seeding, all plates were washed and fixed as previously
described (de Lucia et al., 2020; Smeeth et al., in press). Figure 1
depicts the assay timeline as per the two exposure conditions.
For details on the proliferation assays and fixation methods see
Supplementary Material.
Caffeine Treatments
Caffeine (5 g) was obtained from Sigma (MO, United States)
in powdered form, with a molecular weight of 194.19 g/mol.
Caffeine conditions were as follows: control (no caffeine, media
only); low (0.1 mM, ∼150 mg, ∼1 cup); moderate (0.25 mM,
∼400 mg, ∼2–3 cups); high (0.5 mM, ∼750 mg, ∼5 cups); and
supraphysiological (1.0 mM, ∼1500 mg, ∼10 cups), reflecting
human intake habits and previous animal models (Wentz and
Magavi, 2009; Efsa Panel on Dietetic Products, Nutrition, and
Allergies (NDA), 2015). Caffeine concentrations were calculated
based on previous research stating that 150 mg of caffeine,
the mean caffeine content of a Starbucks cappuccino (Ludwig
et al., 2014), is approximately equivalent to 0.1 mM (Su
et al., 2013a,b). For full details on the caffeine treatments see
Supplementary Material.
Immunocytochemistry
Cell count, progenitor cell integrity, progenitor proliferation, and
cell death were visualized using 4′,6-diamidino-2-phenylindole
(DAPI), Nestin and SRY-Box Transcription Factor 2 (SOX2),
Ki67, and cleaved caspase-3 (CC3), respectively, using
immunocytochemistry as previously described (de Lucia et al.,
2020; Smeeth et al., in press). For protocol details, antibodies
used, and representative images see Supplementary Figure S1.
Image Analysis
Immunostainings were quantified using the semi-automated
CellInsight NXT High Content Screening (HCS) platform
(Thermo Fisher Scientific) and Studio Cell Analysis Software
(Thermo Fisher Scientific), as previously described (de Lucia
et al., 2020; Smeeth et al., in press). This platform relies on
light intensity thresholds, which identify DAPI (wavelength 386)
or secondary antibody fluorescence (wavelengths 488 and 555).
These thresholds, combined with other parameters based on
cell size and shape, identify cells stained by each antibody in
an unbiased way and enable semi-automated quantification of
immunocytochemical stains. Threshold settings were set by an
author blinded to exposure/concentration and parameters were
kept constant across experiments. For further details on the
protocols and parameters used see Supplementary Material.
Statistical Analyses
Data analyses were conducted using IBM SPSS Statistics 26
(IBM Ltd., Portsmouth, United Kingdom). All data were
assessed for normality using probability-probability plots
and the Kolmogorov–Smirnov test, and for homogeneity
of variance using the Levene’s test. For data that did
not conform to normality and/or homoscedasticity non-
parametric statistical tests were applied. To evaluate
differences between DAPI, Ki67, C33, and Ki67/CC3, a
two-way analysis of variance (ANOVA) with a Bonferroni
post hoc correction was applied. To evaluate differences in
SOX2, Nestin, and Nestin/SOX2 a series of Kruskal–Wallis
tests with Dunn’s post hoc corrections were applied. All
tests carried out were two-sided and the alpha criterion
used was p < 0.05. Data are represented as the mean (M)
and standard deviation (SD), or the median (Mdn) and
interquartile range (IQR).
RESULTS
Exposure to Caffeine Reduces Cell
Number
There was no significant interaction of caffeine concentration
and exposure type, i.e., repeated versus acute caffeine treatment,
on cell number, as measured by DAPI-positive cell density
(p = 0.947), nor was there a significant main effect of
exposure (p = 0.580). However, as shown in Figures 2A,B,
there was a main effect of caffeine concentration on DAPI-
positive cell density (p = 0.036), such that higher caffeine
doses reduced cell number. However, due to issues of power,
post hoc analyses revealed no specific differences between
any of the caffeine conditions, but, although not statistically
significant, an observed 58.6% reduction in cell count for the
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FIGURE 1 | Schematic of the proliferation assays for the two caffeine exposure conditions. (A) Acute caffeine exposure. This plate received only one caffeine
treatment, 24 h after seeding. Treatment involved a full replacement of culture medium with 100 µl caffeinated medium. (B) Repeated Caffeine Exposure. This plate
received a treatment every 24 h after seeding. Treatment 1 (Tr1) involved a full replacement of culture medium with 100 µl caffeinated medium. Treatment 2 (Tr2)
involved a “booster” treatment, where 20 µl of medium was removed and replaced with fresh caffeine medium. Booster treatments were made at 5× concentration.
Both plates were fixed 72 h after seeding. ICC, immunocytochemistry. Cell line: HPC0A07/03. Passage number: P21; biological replicates: n = 3; technical
replicates: n = 3.
FIGURE 2 | The effect of caffeine treatment on DAPI-positive cell density. (A) There was no significant interaction of caffeine concentration and exposure on
DAPI-positive cell density [two-way ANOVA: F (4,20) = 0.179, p = 0.947], nor was there a significant main effect of exposure [F (1,20) = 0.317, p = 0.580]. However,
caffeine had a significant main effect on DAPI-positive cell density [one-way ANOVA: F (4,25) = 3.041, p = 0.036]. Post hoc analyses revealed no significant
differences in total cell number between any specific caffeine concentration and the control, nor between any caffeine concentrations. However, a statistically
non-significant reduction in cell count was observed for the supraphysiological caffeine concentration (i.e., 1.0 mM, M = 74.13, SD = 34.27) compared with the
lowest caffeine concentration (i.e., 0.1 mM, M = 171.12, SD = 74.21, p = 0.058). (B) Representative immunostaining, demonstrating DAPI-positive cell density
following exposure to different caffeine concentrations. Images taken at 10× objective; scale bar represents 100 µm. Cell line: HPC0A07/03; passage number: P21;
biological replicates: n = 3; technical replicates: n = 3; data represents the mean (±SD); (adjusted p-values; Bonferroni correction). Graph not stratified by exposure
given that no main effect of exposure was found. Graph presents the pooled data of acute and repeated exposure.
supraphysiological dose (i.e., 1.0 mM ∼ 1500 mg) relative to
the lowest caffeine dose (i.e., 0.1 mM ∼ 150 mg) was seen
(p = 0.058).
Exposure to Supraphysiological Caffeine
Concentrations Reduces Hippocampal
Progenitor Integrity Compared With
Lower Caffeine Doses Only
There was no significant main effect of exposure on hippocampal
progenitor integrity, as measured by both % Nestin-positive
(p = 0.901) and % SOX2-positive (p = 0.917) cells. However,
as shown in Figure 3, there was a significant main effect of
caffeine concentration on both % Nestin-positive (p = 0.034)
and % SOX2-positive cells (p = 0.016), all while controlling
for cell number.
Post hoc analyses revealed that the supraphysiological caffeine
concentration (i.e., 1.0 mM ∼ 1500 mg) significantly reduced
the % Nestin-positive cells by 1.5% relative to the lowest caffeine
concentration (i.e., 0.1 mM∼ 150 mg; p = 0.016; Figures 3A,D).
No significant differences in % Nestin-positive cells for any of
the caffeine concentrations relative to control were observed
(0.1 mM ∼ 150 mg: p > 0.99; 0.25 mM ∼ 400 mg: p > 0.99;
0.5 mM ∼ 750 mg: p > 0.99; 1.0 mM ∼ 1500 mg: p = 0.388).
However, it should be noted that the supraphysiological
caffeine dose was reduced relative to control conditions but
did not survive multiple comparison correction (non-adjusted
p = 0.039).
Similar to Nestin data, post hoc analyses of % SOX2-
positive cells revealed that the supraphysiological caffeine dose
(i.e., 1.0 mM ∼ 1500 mg) significantly reduced % SOX2-
positve cells by 2.3%, again, relative to the lowest caffeine
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FIGURE 3 | The effect of caffeine treatment on% Nestin-,% SOX2-, and Nestin/SOX2-positive cells. (A) There was no significant main effect of exposure on %
Nestin-positive cells (Kruskal–Wallis test, H = 0.02, df = 1, p = 0.901) but there was a significant main effect of caffeine (Kruskal–Wallis test, H = 10.38, df = 4,
p = 0.034). Dunn’s post hoc analyses revealed that the supraphysiological caffeine concentration (i.e., 1.0 mM; Mdn = 97.2, IQR = 1.99) had significantly reduced
stem cell integrity compared with the lowest caffeine concentration (i.e., 0.1 mM, Mdn = 98.66, IQR = 0.72, p = 0.016). (B) There was no significant main effect of
(Continued)
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FIGURE 3 | Continued
exposure on % SOX2-positive cells (Kruskal–Wallis test, H = 0.01, df = 1, p = 0.917) but there was a significant main effect of caffeine (Kruskal–Wallis test,
H = 12.17, df = 4, p = 0.016). Dunn’s post hoc analyses revealed that the supraphysiological caffeine concentration (i.e., 1.0 mM; Mdn = 96.59, IQR = 2.8) was
significantly reduced compared with the lowest caffeine concentration (i.e., 0.1 mM, Mdn = 98.9, IQR = 0.81, p = 0.013). (C) There was no significant main effect of
exposure on % Nestin/SOX2-positive cells (Kruskal–Wallis test, H = 0.03, df = 1, p = 0.868) but there was a significant main effect of caffeine (Kruskal–Wallis test,
H = 11.61, df = 4, p = 0.021). Dunn’s post hoc analyses revealed the supraphysiological caffeine concentration (i.e., 1.0 mM; Mdn = 95.46, IQR = 3.98) was
significantly reduced compared with the lowest caffeine concentration (i.e., 0.1 mM, Mdn = 97.48, IQR = 1.11, p = 0.016). (D) Representative immunostaining,
demonstrating, in order from the top panel, DAPI-positive cell density, % Nestin-, % SOX2-, and % Nestin/SOX2-positive cells following exposure to different caffeine
concentrations. Images taken at 10× objective; scale bar represents 100 µm. % Nestin-, % SOX2-, and % Nestin/SOX2-positive cells are controlled for by DAPI.
Cell line: HPC0A07/03; passage number: P21; biological replicates: n = 3; technical replicates: n = 3; Data represents the median (±IQR); ∗p < 0.05; (adjusted
p-values; Dunn’s correction). Graphs not stratified by exposure given that no main effect of exposure was found. Graphs present the pooled data of acute and
repeated exposure.
concentration (0.1mM ∼ 150 mg, p = 0.013; Figures 3B,D).
Moreover, there was an observed reduction, albeit not statistically
significant, in % SOX2-positive cells in the supraphysiological
caffeine dose relative to the moderate caffeine concentration, i.e.,
0.25 mM ∼ 400 mg (p = 0.059). Again, no significant differences
were observed relative to control conditions (0.1 mM ∼ 150 mg:
p ≥ 0.99; 0.25 mM ∼ 400 mg: p > 0.99; 0.5 mM ∼ 750 mg:
p > 0.99; 1.0 mM ∼ 1500 mg: p = 0.304). However, as with
the Nestin data, % SOX2-positive cells in the supraphysiological
caffeine condition were reduced relative to control but did not
survive multiple comparison correction (non-adjusted p = 0.03).
Unsurprisingly, a similar results pattern was observed for %
Nestin/SOX2-positve cells. Specifically, no significant main effect
of exposure (p = 0.868) was observed, but there was a significant
main effect of caffeine on % Nestin/SOX2-positive cells
(p = 0.021), with the supraphysiological concentration reducing
% Nestin/SOX2-positve cells by 2.1% relative to the lowest
caffeine concentration only (p = 0.016; Figures 3C,D). Moreover,
the % Nestin/SOX2-positive cells for the supraphysiological
dose was reduced compared with the control condition (non-
adjusted p = 0.029) and the moderate caffeine concentration, i.e.,
0.25 mM ∼ 400 mg (non-adjusted p = 0.008) but these did not





There was no significant interaction effect of caffeine and
exposure on proliferation, as measured by the percentage of Ki67-
positive cells (p = 0.102). However, as shown in Figures 4A,D,
there was both a significant main effect of exposure (p = 0.009)
and caffeine concentration (p < 0.001) on the % Ki67-positive
cells, all while controlling for cell number. Specifically, repeated
exposure to the supraphysiological caffeine concentration (i.e.,
1.0 mM ∼ 1500 mg) significantly reduced proliferation by
37% relative to control conditions (p = 0.001), by 39.5%
relative to the lowest caffeine dose (i.e., 0.1 mM ∼ 150 mg;
p < 0.001), and by 37.7% relative to the moderate caffeine
dose (i.e., 0.25 mM ∼ 400 mg; p = 0.001). No significant
differences were found between the control condition and the
other caffeine concentrations, i.e., 0.1 mM (p > 0.99), 0.25 mM
(p > 0.99), and 0.5 mM (p = 0.446), nor were any significant
differences observed for acute exposure, that is, a single, one-time
caffeine treatment.
Exposure to Caffeine Does Not Affect
Apoptosis
As depicted in Figures 4B,D, there was no significant interaction
of caffeine concentration and exposure on apoptosis, as measured
by % CC3-positive cells (p = 0.616), nor was there a significant
main effect of exposure (p = 0.571) or caffeine concentration
(p = 0.474) – all while controlling for cell number. Furthermore,
as shown in Figures 4C,D, there was no significant interaction of
caffeine concentration and exposure on proliferative cell death,
as measured by % Ki67/CC3-positive cells (p = 0.797), nor
was there a significant main effect of exposure (p = 0.759) or
caffeine concentration (p = 0.167) – again, all while controlling
for cell number.
DISCUSSION
In this study we explore the effects of acute and repeated caffeine
exposure at different concentrations on hippocampal progenitor
proliferation, integrity, and apoptosis, using an in vitro
hippocampal cellular model. We demonstrate that a repeated
supraphysiological dose of caffeine, i.e., 1.0 mM ∼ 1500 mg
or ∼10 cups of coffee, significantly reduces progenitor
proliferation, as measured by % Ki67-positive cells, relative
to the control condition (no caffeine) and to both the lowest
(i.e., 0.1 mM ∼ 150 mg or ∼1 cup) and moderate (i.e.,
0.25 mM ∼ 400 mg or 2–3 cups) caffeine concentrations.
Moreover, the supraphysiological dose (∼10 cups of coffee),
whether acutely or repeatedly administered, negatively influences
progenitor integrity, as measured by both % Nestin- and %
SOX2-positve cells, but only when compared with the lowest
caffeine dose (∼1 cup of coffee). Finally, we show that caffeine,
irrespective of the degree of exposure or concentration, does
not affect overall, or proliferative, cell death, as measured by %
CC3-positive cells and % Ki67/CC3-positive cells, respectively.
Our finding that repeated treatment with a supraphysiological
caffeine concentration, that is, intake of ∼10 cups of coffee,
reduces hippocampal progenitor proliferation directly contrasts
previous findings from Wentz and Magavi (2009), who used an
animal model and observe that supraphysiological doses increase
proliferation. However, this inconsistency could be attributed
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FIGURE 4 | The effect of caffeine treatment on % Ki67-, % CC3-, and % Ki67/CC3-positive cells. (A) There was no significant interaction effect of caffeine
concentration and exposure on % Ki67-positive cells [two-way ANOVA: F (4,20) = 2.235, p = 0.102]. However, a significant main effect of both exposure [two-way
ANOVA: F (1,20) = 8.292, p = 0.009], and caffeine concentration [two-way ANOVA: F (4,20) = 9.81, p < 0.001] was found on % Ki67-positive cells. Specifically,
Bonferroni post hoc analyses revealed that repeated treatment with the supraphysiological concentration (i.e., 1.0 mM; M = 39.05, SD = 7.5) significantly reduced
(Continued)
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FIGURE 4 | Continued
proliferation compared with the control (M = 61.94, SD = 6.69, p = 0.001), the lowest caffeine dose (i.e., 0.1 mM; M = 64.580, SD = 4.403, p < 0.001), and the
moderate caffeine dose (i.e., 0.25 mM; M = 62.68, SD = 6.35, p = 0.001). (B) There was no significant main effect of caffeine [one-way ANOVA: F (4,25) = 9.09,
p = 0.474], exposure [two-way ANOVA: F (1,20) = 0.331, p = 0.571], nor an interaction effect [two-way ANOVA: F (4,20) = 0.677, p = 0.616] on apoptosis, that is %
CC3-positive cells. (C) There was no significant main effect of caffeine [one-way ANOVA: F (4,25) = 1.767, p = 0.167], exposure [two-way ANOVA: F (1,20) = 0.097,
p = 0.759], nor an interaction effect [two-way ANOVA: F (4,20) = 0.413, p = 0.797] on % CC3/Ki67-positive cells. (D) Representative immunostaining, demonstrating,
in order from the top panel, DAPI-positive cell density, % Ki67-, % CC3-, and % Ki67/CC3-positive cells following exposure to different caffeine concentrations.
Images taken at 10× objective; scale bar represents 100 µm. % Ki67-, % CC3-, and % Ki67/CC3-positive cells are controlled for by DAPI. Cell line: HPC0A07/03;
passage number: P21; biological replicates: n = 3; technical replicates: n = 3; data represents the mean (±SD); ∗∗p < 0.01 (adjusted p-values; Bonferroni correction).
Graphs (B,C) are not stratified by exposure given that no main effect of exposure was found. Graphs (B,C) present the pooled data of acute and repeated exposure.
to differences in study design; all previous findings were from
an animal model, and therefore are not entirely translatable
to our own study design that uses a human in vitro cellular
model. Furthermore, our study found no effect of lower caffeine
doses on hippocampal proliferation, despite previous literature
demonstrating a decrease in proliferation (Han et al., 2007;
Wentz and Magavi, 2009). While the discrepancies between
our findings and that of the previous literature could be a
consequence of the different models used, it is more likely
attributable to the different timescales investigated. While our
study investigated repeated exposure over 72-h of proliferation,
Wentz and Magavi (2009) and Han et al. (2007) investigated
caffeine exposure over 7 days and 4 weeks, respectively. In
the context of our work, while the supraphysiological caffeine
concentration is strong enough to produce a detrimental effect
over a short period of time, our 72-h paradigm may be insufficient
to replicate the results seen from chronic exposure with lower,
more physiologically relevant doses. Therefore, future work
should seek to extend our paradigm to explore the longer-
term effects of chronic, rather than repeated treatment, with
physiologically relevant caffeine concentrations.
Previously unexplored within an in vitro model of HPCs,
our findings relating to % Nestin- and % SOX2-positive cells
may provide some insight into the mechanisms by which the
supraphysiological caffeine dose influences proliferation. Used
as markers for progenitor integrity in this study, Nestin and
SOX2 represent the maintenance of the stem cell pool, with
their knockout having been shown to lead to a reduction in
total neural stem cell (NSC) quantity (Favaro et al., 2009;
Park et al., 2010). In particular, SOX2 has been implicated as
an important requirement for the maintenance of self-renewal
and pluripotency in human embryonic hippocampal progenitors
(Fong et al., 2008), and this has been further demonstrated in
adult neural hippocampal progenitors. Ferri et al. (2004) found
that knocking down SOX2 leads to reduced proliferation and a
depletion of the neural hippocampal progenitor pool – a finding
seemingly consistent with our own. Indeed, we report a reduction
in both % Nestin-, % SOX- and % Nestin/SOX2-positive cells, and
simultaneously find no change in either the total % CC3-positive
cells or % CC3/Ki67-positive cells (i.e., specifically proliferative
cell death), suggesting that the observed decrease in proliferation
following repeated supraphysiological caffeine treatment could
stem from a reduction in the hippocampal progenitor pool
itself. However, given that Ki67 was not co-labeled with SOX2,
this requires further substantiation. We do not know if the
observed reduction in % Ki67-positive cells derive directly from
the observed decrease in % SOX2-positive cells. It is possible
that the two may be independent; our findings for proliferation
could pertain to a reduction in the proliferative capacity and/or
speed of NSCs rather than as a knock-on effect of a reduced
progenitor pool.
Interestingly, we find no statistically significant effect of
supraphysiological caffeine doses on SOX2 relative to control
conditions, however we believe that this could potentially be due
to issues of power (Cremers et al., 2017), given that prior to
post hoc adjustment, the supraphysiological concentration of∼10
cups of coffee shows a reduction in both % Nestin-, % SOX2-,
and % Nestin/Ki67-positve cells, all relative to control conditions.
Furthermore, it is notable that hippocampal progenitor integrity
was statistically assessed using non-parametric methods, which
are typically less powerful than parametric equivalents (Siegel,
1957). Therefore, it would be highly profitable for future research
to include a greater sample size to more fully elucidate the effect
of supraphysiological caffeine concentrations on hippocampal
progenitor integrity.
The precise mechanisms by which caffeine affects proliferation
are widely unknown, but the observed changes to % SOX2-
positive cells may provide some insight. Caffeine has commonly
been associated with protein kinase B (PKB or Akt) signaling;
specifically, it has been attributed to downregulating Akt
signaling in a wide range of cell types, from HeLa to
mouse epidermal cell lines (Nomura et al., 2005; Saiki
et al., 2011). Pertinently, Akt signaling has been linked
with SOX2, having been shown to promote the expression
of SOX2 adult hippocampal neural progenitor cells (Peltier
et al., 2010). Furthermore, Akt signaling itself decreases with
age, akin to SOX2 expression and neurogenesis overall, but
its reactivation has been shown to ameliorate age-related
defects in neuronal development (Tang et al., 2019). It is
therefore possible that our finding of reduced%SOX2-positve
cells following supraphysiological caffeine treatment is a product
of downregulated Akt signaling. To our knowledge, the effect
of caffeine on Akt signaling within an HPC cell line has not
yet been investigated, and therefore future research would be
instrumental in validating a link between caffeine and SOX2
expression in HPCs and revealing whether this action could be
mediated by Akt signaling.
While our work reveals a negative effect of supraphysiological
caffeine on human hippocampal progenitor integrity and
proliferation, there are some limitations in that our model
may have influenced the extent to which caffeine affects this
process. For example, caffeine is metabolized in the liver by
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the enzyme CYP1A2, which accounts for approximately 90%
of caffeine metabolism (Arnaud, 2011). Interestingly, a C/A
polymorphism in intron 1 of the CYP1A2 gene appears to affect
CYP1A2 enzymatic activity, and ultimately alter the rate of
caffeine metabolism (Sachse et al., 2001). Indeed, Butler et al.
(1992) defined CYP1A2 activity as being trimodally distributed,
with slow, intermediate, and rapid metabolizers, as determined
by caffeine urinary metabolite analyses. Essentially, the rates of
caffeine clearance differ depend on an individual’s genetic variant,
and therefore the amount of time that caffeine is present in the
systemic environment is subject to interindividual differences.
These differences in caffeine metabolic rates have been associated
with differences in the risk of some neurodegenerative diseases,
with individuals possessing the C allele, i.e., slow metabolizers,
having decreased caffeine-related risk of Parkinson’s Disease
(Popat et al., 2011; Chuang et al., 2016). Therefore, it is possible
that this polymorphism may also mediate differences in the way
caffeine affects proliferation, especially considering that caffeine
reaches the brain via the systemic environment. Our study
measures the direct effect of caffeine exposure on hippocampal
progenitor cells, without accounting for differential metabolic
rates in the liver caused by the CYP1A2 polymorphism.
Furthermore, while the caffeine concentrations used in our
study reflect “intake,” this is not representative of peak plasma
levels obtained following caffeine metabolism. Indeed, around
99% of caffeine is metabolized into paraxanthine, theobromine,
and theophylline (Arnaud, 1993; Nehlig, 2018) and, thus, only
residual caffeine remains in the systemic environment. For
instance, consumption of 160 mg of caffeine, in the form
of a hot coffee, was shown to produce an average peak
plasma level of 3.74 µg/mL, or 19.26 µM, in humans (White
et al., 2016). The lowest caffeine concentration in our study,
0.1 mM, represents approximately 150 mg of caffeine (Su
et al., 2013a,b), or one Starbucks cappuccino (Ludwig et al.,
2014), whereas plasma caffeine levels typically reach between 20
and 50 µM (Graham, 2001). Therefore, the levels of caffeine
tested in this study reflect supranutritional doses, not the
physiologically relevant concentrations that would reach the
neurogenic niche in vivo. However, this study provides proof
of concept that caffeine can modulate hippocampal progenitor
proliferation, but it would be profitable for future research
to investigate the effects of nutritional and supranutritional
caffeine concentrations on this process over time. Understanding
when in the trajectory of the neurogenic process these changes
occur would be hugely beneficial for developing more targeted
prevention strategies. Applying a growth curve analysis strategy
to the proliferation and differentiation assays could be a
viable solution.
An additional limitation to our work is that although CC3 is
a commonly used maker for apoptosis, there are multiple modes
of cell death, and even several pathways of apoptotic cell death
(Galluzzi et al., 2018) that cannot be captured by a single marker,
and particularly under stressful conditions in vivo (Riegelsberger
et al., 2011). Thus, although we observe no change in apoptosis
in the context of our work, additional makers (e.g., Annexin and
TUNEL) would provide a more comprehensive overview of the
apoptotic process.
Furthermore, although our aim was to explore the effect of
caffeine on hippocampal progenitor cells, given that diet has been
shown to specifically influence neural hippocampal progenitor
behavior (Spéder et al., 2011; Sakayori et al., 2013), our work
would hugely benefit from exploring the impact of caffeine
on neural progenitor differentiation. By only investigating
proliferation, we do not know what longer-term, knock-on
effects might arise from caffeine treatment, with respect to
differentiation and/or survival. Given that early changes to
the hippocampal progenitor pool can reduce neurogenesis and
result in morphological abnormalities of the resulting neurons
(Cavallaro et al., 2008), future work should seek to extend our
paradigm to also evaluate the impact of caffeine on differentiation
and neuron morphology in order to more fully capture the impact
of caffeine on the neurogenic process as a whole.
Finally, it is important to acknowledge that cell models are
somewhat removed from an in vivo system making it challenging
to account for any organism-wide changes. Furthermore, our
model specifically is hindered by the lack of microglia, which
play a key role in NSC regulation (Cunningham et al., 2013; Liu
et al., 2013) and by the use of fetal NSCs to study proliferation
during later life stages. Additionally, our findings should be
interpreted with caution when generalizing to both male and
females, given that this is a female cell line. Research shows
sexual dimorphism in cognition (Ycaza Herrera et al., 2019),
caffeine metabolism (Adan et al., 2008; Denden et al., 2016) and
neurogenesis (Greiner et al., 2019).
However, despite these limitations to our work, this study is
the first, to our knowledge, to investigate the direct effects of
caffeine on hippocampal progenitor proliferation and integrity
using a human in vitro cellular model. NSC proliferation is
influenced by a range of systemic and environmental factors
that are difficult to control for in an in vivo environment (Azari
and Reynolds, 2016) – an issue that is mostly controlled for in
in vitro models. Moreover, species and strain differences have
long been a criticism of animal models (Martić-Kehl et al., 2012),
and proliferation in particular has been shown to widely differ
amongst mammalian species (Amrein et al., 2011). Therefore,
our work investigates the direct effect of caffeine on human
hippocampal stem cell proliferation and is thus likely to yield
results with greater translational value.
Additionally, it is worth mentioning that our results have
implications beyond the impact of metabolites or drugs on
learning, aging, and cognitive decline. Indeed, recent research
has highlighted the interaction of certain drugs with NSCs
(Ikhsan et al., 2019), something with which our results are in
strong accordance. Notably, there is a strong evidence base
demonstrating a clear interaction of antidepressants with NSCs
(Santarelli et al., 2003; Anacker et al., 2011), producing an
increase in hippocampal progenitor proliferation. However, there
is limited data available for substances beyond antidepressants
(Ikhsan et al., 2019), especially concerning those of a non-
pharmacological nature. Therefore, not only do our findings
contribute to the growing discussion surrounding drug-NSC
interactions, but they also provide evidence of such an interaction
with a dietary-based substance, highlighting the possibility of
utilizing diet as a non-pharmacological intervention to positively
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influence hippocampal neurogenesis. However, further research
is required to identify positive dietary components and fully
elucidate their interaction with NSCs and their effect on
hippocampal neurogenesis.
CONCLUSION
In summary, our study demonstrates that dietary components
such as caffeine can influence hippocampal progenitor
proliferation and may be indicative of one mechanism by
which diet affects cognitive outcomes. However, future research
that (i) further explores the effects of human consumption-
related caffeine doses on both neural progenitor proliferation
and differentiation, and (ii) correlates this with cognitive
outcomes, are now needed.
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